pubmed.ncbi.nlm.nih.gov

Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3 - PubMed

️Sun Jan 01 1995

Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3

G Zhouravleva et al. EMBO J. 1995.

Abstract

Termination of translation in higher organisms is a GTP-dependent process. However, in the structure of the single polypeptide chain release factor known so far (eRF1) there are no GTP binding motifs. Moreover, in prokaryotes, a GTP binding protein, RF3, stimulates translation termination. From these observations we proposed that a second eRF should exist, conferring GTP dependence for translation termination. Here, we have shown that the newly sequenced GTP binding Sup35-like protein from Xenopus laevis, termed eRF3, exhibits in vitro three important functional properties: (i) although being inactive as an eRF on its own, it greatly stimulates eRF1 activity in the presence of GTP and low concentrations of stop codons, resembling the properties of prokaryotic RF3; (ii) it binds and probably hydrolyses GTP; and (iii) it binds to eRF1. The structure of the C-domain of the X.laevis eRF3 protein is highly conserved with other Sup35-like proteins, as was also shown earlier for the eRF1 protein family. From these and our previous data, we propose that yeast Sup45 and Sup35 proteins belonging to eRF1 and eRF3 protein families respectively are also yeast termination factors. The absence of structural resemblance of eRF1 and eRF3 to prokaryotic RF1/2 and RF3 respectively, may point to the different evolutionary origin of the translation termination machinery in eukaryotes and prokaryotes. It is proposed that a quaternary complex composed of eRF1, eRF3, GTP and a stop codon of the mRNA is involved in termination of polypeptide synthesis in ribosomes.

PubMed Disclaimer

Cited by

Selective inhibition of human translation termination by a drug-like compound.
Li W, Chang ST, Ward FR, Cate JHD. Li W, et al. Nat Commun. 2020 Oct 2;11(1):4941. doi: 10.1038/s41467-020-18765-2. Nat Commun. 2020. PMID: 33009412 Free PMC article.
Michael Ter-Avanesyan (1949-2018) - life in science.
Kushnirov VV. Kushnirov VV. Prion. 2019 Jan;13(1):37-40. doi: 10.1080/19336896.2019.1567201. Prion. 2019. PMID: 30633633 Free PMC article.
Translation termination in eukaryotes: polypeptide release factor eRF1 is composed of functionally and structurally distinct domains.
Frolova LY, Merkulova TI, Kisselev LL. Frolova LY, et al. RNA. 2000 Mar;6(3):381-90. doi: 10.1017/s135583820099143x. RNA. 2000. PMID: 10744022 Free PMC article.
Distinct paths to stop codon reassignment by the variant-code organisms Tetrahymena and Euplotes.
Salas-Marco J, Fan-Minogue H, Kallmeyer AK, Klobutcher LA, Farabaugh PJ, Bedwell DM. Salas-Marco J, et al. Mol Cell Biol. 2006 Jan;26(2):438-47. doi: 10.1128/MCB.26.2.438-447.2006. Mol Cell Biol. 2006. PMID: 16382136 Free PMC article.
Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals.
Fang J, Pietzsch C, Witwit H, Tsaprailis G, Crynen G, Cho KF, Ting AY, Bukreyev A, Saphire EO, de la Torre JC. Fang J, et al. Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2201208119. doi: 10.1073/pnas.2201208119. Epub 2022 Jul 18. Proc Natl Acad Sci U S A. 2022. PMID: 35858434 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1971 Mar;68(3):619-24 - PubMed
1. Nature. 1994 Dec 15;372(6507):701-3 - PubMed
1. Biochem J. 1976 Dec 15;160(3):505-19 - PubMed
1. J Biol Chem. 1977 Jul 10;252(13):4514-20 - PubMed
1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 - PubMed

Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3 - PubMed